NCT04440254View on ClinicalTrials.gov

Long Duration Holter ECG in Fabry Disease

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions
Fabry Disease
Interventions
DIAGNOSTIC_TEST

Implantation (subcutaneous) of a marketed miniaturized Holter ECG recording device

Subcutaneously implanted under local anesthesia of the device on the presternal or subclavicular region

Trial Locations (1)

75015

RECRUITING

20 Rue Leblanc, HEGP/PARCC, 75015 Paris, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV